Results: 28
Issue Information.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 543, doi. 10.1111/all.16072
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 545, doi. 10.1111/all.16071
- Publication type:
- Article
Drug hypersensitivity: Past, present and future.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 549, doi. 10.1111/all.16050
- By:
- Publication type:
- Article
Infant lung function and early skin barrier impairment in the development of asthma at age 3 years.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 667, doi. 10.1111/all.16024
- By:
- Publication type:
- Article
Recent patents in allergy and immunology: Transepidermal water loss for anaphylaxis monitoring.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 765, doi. 10.1111/all.16017
- By:
- Publication type:
- Article
Sialylation of IgE does not impact its interaction with FcεRI.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 761, doi. 10.1111/all.16014
- By:
- Publication type:
- Article
Regulation of mast cells by overlapping but distinct protein interactions of Siglec‐6 and Siglec‐8.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 629, doi. 10.1111/all.16004
- By:
- Publication type:
- Article
Plasma protein signatures of adult asthma.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 643, doi. 10.1111/all.16000
- By:
- Publication type:
- Article
EAACI/ENDA position paper on drug provocation testing.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 565, doi. 10.1111/all.15996
- By:
- Publication type:
- Article
Turning nature's experiment into a cure.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 767, doi. 10.1111/all.15981
- By:
- Publication type:
- Article
Glatiramer acetate induces mast cell degranulation via MRGPRX2, implications for local and systemic adverse reactions.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 758, doi. 10.1111/all.15978
- By:
- Publication type:
- Article
Risk of anaphylaxis after COVID‐19 vaccination in South Korea: A nationwide self‐controlled case series analysis.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 754, doi. 10.1111/all.15975
- By:
- Publication type:
- Article
Occupational anaphylaxis—Data from the anaphylaxis registry.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 702, doi. 10.1111/all.15974
- By:
- Publication type:
- Article
Hypersensitivity reactions to human albumin—A case series and diagnostic algorithm.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 752, doi. 10.1111/all.15971
- By:
- Publication type:
- Article
Changing patterns in the epidemiology of drug allergy.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 613, doi. 10.1111/all.15970
- By:
- Publication type:
- Article
Global burden of vaccine‐associated anaphylaxis and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 690, doi. 10.1111/all.15968
- By:
- Publication type:
- Article
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 552, doi. 10.1111/all.15961
- By:
- Publication type:
- Article
Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 580, doi. 10.1111/all.15957
- By:
- Publication type:
- Article
Statistical advice provided by ChatGPT regarding an accepted article in Allergy.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 748, doi. 10.1111/all.15956
- By:
- Publication type:
- Article
A phase 2 open‐label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 724, doi. 10.1111/all.15948
- By:
- Publication type:
- Article
Prophylactic use of diquafosol eye drops for dupilumab‐associated conjunctivitis in patients with severe atopic dermatitis: An open‐label prospective study.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 746, doi. 10.1111/all.15943
- By:
- Publication type:
- Article
Allergological reappraisal of the Annex to the European Commission guideline on excipients (SANTE‐2017‐11,668).
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 735, doi. 10.1111/all.15913
- By:
- Publication type:
- Article
Biomarkers of immediate drug hypersensitivity.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 601, doi. 10.1111/all.15933
- By:
- Publication type:
- Article
Nestin drives allergen‐induced airway smooth muscle hyperplasia and airway remodeling.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 744, doi. 10.1111/all.15932
- By:
- Publication type:
- Article
Resolvin D2 regulates type 2 inflammatory responses and promotes resolution of mouse allergic inflammation.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 739, doi. 10.1111/all.15920
- By:
- Publication type:
- Article
Tezepelumab decreases airway epithelial IL‐33 and T2‐inflammation in response to viral stimulation in patients with asthma.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 656, doi. 10.1111/all.15918
- By:
- Publication type:
- Article
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 679, doi. 10.1111/all.15940
- By:
- Publication type:
- Article
Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
- Published in:
- Allergy, 2024, v. 79, n. 3, p. 711, doi. 10.1111/all.15911
- By:
- Publication type:
- Article